LOS ANGELES, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)UNIVERSITY KIDNEY RESEARCH ORGANIZATION CO KLEINBERG LANGE CUDDY & CARLO LLP, founded in 2002, is a small nonprofit in the Medical Research sector that reported $111K in total revenue in fiscal year 2024. Revenue fell 71% from the prior year — a significant decline worth monitoring. Expenses of $239K exceeded revenue, resulting in a 115% operating deficit.
UNIVERSITY KIDNEY RESEARCH ORGANIZATION SUPPORTS MEDICAL RESEARCH RELATED TO THEPREVENTION, TREATMENT, AND ERADICATION OF KIDNEY DISEASE. UKRO FUNDRAISES TO SUPPORTTHE SYNTHETIC KIDNEY PROJECT AT THE NEWLY NAMED VITO M. CAMPESE, M.D./UKRO KIDNEY RESEARCH CENTER OF USC.
IN APRIL 2024, UKRO MADE A GIFT OF $100,000 TO THE KECK SCHOOL OF MEDICINE OF USC TO SUPPORT THE SYNTHETIC KIDNEY PROJECT.IN DECEMBER 2024, UKRO MADE A DONOR-DIRECTED GIFT OF $15,000 TO THE KECK...
IN APRIL 2024, UKRO MADE A GIFT OF $100,000 TO THE KECK SCHOOL OF MEDICINE OF USC TO SUPPORT THE SYNTHETIC KIDNEY PROJECT.IN DECEMBER 2024, UKRO MADE A DONOR-DIRECTED GIFT OF $15,000 TO THE KECK SCHOOL OF MEDICINE OF USC TO FUND THE RE-HIRING OF A KEY RESEARCHER ON THE SYNTHETIC KIDNEY PROJECT TEAM.
THROUGH ITS WEBSITE, ONLINE SOCIAL MEDIA PRESENCE, AND E-NEWSLETTERS, THE ORGANIZATION RAISES AWARENESS OF KIDNEY DISEASE AND RESEARCH BREAKTHROUGHS, PARTICULARLY SPOTLIGHTING THE WORK OF SCIENTISTS...
THROUGH ITS WEBSITE, ONLINE SOCIAL MEDIA PRESENCE, AND E-NEWSLETTERS, THE ORGANIZATION RAISES AWARENESS OF KIDNEY DISEASE AND RESEARCH BREAKTHROUGHS, PARTICULARLY SPOTLIGHTING THE WORK OF SCIENTISTS AT THE NEWLY NAMED VITO M. CAMPESE, M.D./UKRO KIDNEY RESEARCH CENTER AND THE KECK SCHOOL OF MEDICINE OF USC.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $110,733 | $377,635 | -0.7% |
| Expenses | $238,586 | $534,645 | -0.6% |
| Net Income | $-127,853 | $-157,010 | -0.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| MICHELLE FAIRCHILD | Secretary | 32.00 |
Officer
|
$65,004 | $0 | $65,004 |
| LEWIS KLEINBERG | President | 3.00 |
Officer
Director
|
$2,000 | $0 | $2,000 |
| AMMIEL NAJAR | Director | 3.00 |
Director
|
$2,000 | $0 | $2,000 |
| KENNETH KLEINBERG | CEO | 6.00 |
Officer
Director
|
$0 | $0 | $0 |
| CAMILA KOENIG | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| ADELA KOENIG | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| JACK BLACK | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| HELEN KLEINBERG | Director | 6.00 |
Director
|
$0 | $0 | $0 |
| JEAN CHEN SHIH PHD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| OLIVER T BROOKS MD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| RICHARD J GLASSOCK MD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| LESLIE GOLDSTEIN | CFO | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| VITO M CAMPESE MD | Director | 3.00 |
Director
|
$0 | $0 | $0 |
| YUICHI IWAKI MD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| ALFRED S NEWMAN | Director | 3.00 |
Director
|
$0 | $0 | $0 |
| SYED ARIF RIZVI MD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| MIGUEL KOENIG | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| JEFFREY MARKLEY | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| YASIR QAZI MD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| MANFRED MOSK PHD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| LISA DETANNA | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| HEDIEH BOLOUR | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| ANDREW MCMAHON PHD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $110,733 | $238,586 | $289,010 | $-127,853 |
| 2023 | $377,635 | $534,645 | $416,863 | $-157,010 |
| 2022 | $750,980 | $344,619 | $573,873 | $406,361 |
| 2021 | $132,989 | $127,343 | $167,512 | $5,646 |
| 2020 | $96,533 | $189,051 | $162,275 | $-92,518 |
| 2019 | $368,910 | $408,761 | $254,528 | $-39,851 |
| 2018 | $61,811 | $272,686 | $294,304 | $-210,875 |
Compare UNIVERSITY KIDNEY RESEARCH ORGANIZATION CO KLEINBERG LANGE CUDDY & CARLO LLP with other nonprofits in California and across the country.